Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liping Pan

Showing results (201-210 of 212) with videos related to

Pageof 22
Sort By:
Frontiers in Cellular and Infection Microbiology|June 27, 2022
Simultaneous Detection of Pathogens and Tumors in Patients With Suspected Infections by Next-Generation SequencingJiachun Su, Xu Han, Xiaogang Xu, et al.
Frontiers in Microbiology|April 18, 2022
Diagnostic Performance of a Novel <i>CXCL10</i> mRNA Release Assay for <i>Mycobacterium tuberculosis</i> InfectionLiping Pan, Mailing Huang, Hongyan Jia, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 22, 2017
Fasiglifam (TAK-875) Alters Bile Acid Homeostasis in Rats and Dogs: A Potential Cause of Drug Induced Liver InjuryFrancis S Wolenski, Andy Z X Zhu, Mike Johnson, et al.
Cancer|March 31, 2012
Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activityChristie Eheman, S Jane Henley, Rachel Ballard-Barbash, et al.
BMC Medical Education|February 14, 2024
A training program for improving the capacity of infection high-throughput sequencing and diagnosis in ChinaDong Zhang, Yunfeng Cheng, Yuan Ji, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 21, 2004
Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and selective histamine H3 receptor antagonist with drug-like propertiesTimothy A Esbenshade, Gerard B Fox, Kathleen M Krueger, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2006
Adamantane sulfone and sulfonamide 11-beta-HSD1 InhibitorsBryan Sorensen, Martin Winn, Jeff Rohde, et al.
Journal of Medicinal Chemistry|October 9, 2007
Synthesis, potency, and in vivo profiles of quinoline containing histamine H3 receptor inverse agonistsRobert J Altenbach, Huaqing Liu, Patricia N Banfor, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2006
Discovery of adamantane ethers as inhibitors of 11beta-HSD-1: Synthesis and biological evaluationJyoti R Patel, Qi Shuai, Jurgen Dinges, et al.
Biochemical Pharmacology|March 21, 2007
Novel heterocyclic-substituted benzofuran histamine H3 receptor antagonists: in vitro properties, drug-likeness, and behavioral activityMarlon Cowart, Gregory A Gfesser, Kaitlin E Browman, et al.
Pageof 22

Showing results (201-210 of 212) with videos related to

Sort By:
Pageof 22
Frontiers in Cellular and Infection Microbiology|June 27, 2022
Simultaneous Detection of Pathogens and Tumors in Patients With Suspected Infections by Next-Generation SequencingJiachun Su, Xu Han, Xiaogang Xu, et al.
Frontiers in Microbiology|April 18, 2022
Diagnostic Performance of a Novel <i>CXCL10</i> mRNA Release Assay for <i>Mycobacterium tuberculosis</i> InfectionLiping Pan, Mailing Huang, Hongyan Jia, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 22, 2017
Fasiglifam (TAK-875) Alters Bile Acid Homeostasis in Rats and Dogs: A Potential Cause of Drug Induced Liver InjuryFrancis S Wolenski, Andy Z X Zhu, Mike Johnson, et al.
Cancer|March 31, 2012
Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activityChristie Eheman, S Jane Henley, Rachel Ballard-Barbash, et al.
BMC Medical Education|February 14, 2024
A training program for improving the capacity of infection high-throughput sequencing and diagnosis in ChinaDong Zhang, Yunfeng Cheng, Yuan Ji, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 21, 2004
Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and selective histamine H3 receptor antagonist with drug-like propertiesTimothy A Esbenshade, Gerard B Fox, Kathleen M Krueger, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2006
Adamantane sulfone and sulfonamide 11-beta-HSD1 InhibitorsBryan Sorensen, Martin Winn, Jeff Rohde, et al.
Journal of Medicinal Chemistry|October 9, 2007
Synthesis, potency, and in vivo profiles of quinoline containing histamine H3 receptor inverse agonistsRobert J Altenbach, Huaqing Liu, Patricia N Banfor, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2006
Discovery of adamantane ethers as inhibitors of 11beta-HSD-1: Synthesis and biological evaluationJyoti R Patel, Qi Shuai, Jurgen Dinges, et al.
Biochemical Pharmacology|March 21, 2007
Novel heterocyclic-substituted benzofuran histamine H3 receptor antagonists: in vitro properties, drug-likeness, and behavioral activityMarlon Cowart, Gregory A Gfesser, Kaitlin E Browman, et al.
Pageof 22